De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?

Published:2022-06 Issue:4 Volume:22 Page:336-342
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Merfeld Emily C.^ORCID,Burr Adam R.,Brickson Claire,Neuman Heather B.,Anderson Bethany M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update;Fisher;Cancer,1983

2. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories;Pugliese;Ann Surg Oncol,2009

3. AJCC Cancer Staging Manual;Amin,2017

4. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial;Galimberti;Lancet Oncol,2013

5. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000;Sola;Ann Surg Oncol,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postmastectomy radiation therapy in breast cancer patients with micrometastatic disease in sentinel node dissection: A cohort study and meta-analysis;Clinical and Translational Radiation Oncology;2024-05

2. Update on Sentinel Lymph Node Methods and Pathology in Breast Cancer;Diagnostics;2024-01-24

3. The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer;Journal of Personalized Medicine;2023-10-08

4. Prognosis and local treatment strategies of breast cancer patients with different numbers of micrometastatic lymph nodes;World Journal of Surgical Oncology;2023-07-10

5. Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection;Frontiers in Surgery;2023-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3